KRTAP19-11P

Across TCGA pan-cancer cohorts, KRTAP19-11P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KRTAP19-11P data layer.

The strongest signal is observed in thymoma (THYM), where higher KRTAP19-11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP19-11P expression acts as an unfavorable survival marker.

THYM, ESCA, and HNSC are the cancer types where KRTAP19-11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.095	0.879	<.001	81	view →
ESCA	OS	Tertile	II,III,IV	0.199	0.707	<.001	63	view →
HNSC	OS	Tertile	IV	0.156	0.708	.007	54	view →
BLCA	DFS	Tertile	All	0.096	0.626	<.001	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
LGG	OS	Tertile	All	0.221	0.889	<.001	24	view →
STAD	DFS	Tertile	All	0.177	0.714	<.001	9	view →
LIHC	DFS	Tertile	All	0.014	0.527	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KRTAP19-11P–THYM (DFS)

Open the THYM breakdown →